Literature DB >> 20698039

Effect of medical and surgical treatment of Barrett's metaplasia.

Eelco B Wassenaar1, Brant K Oelschlager.   

Abstract

Barrett's esophagus (BE) is a change in the esophageal mucosa as a result of long-standing gastroesophageal reflux disease. The importance of BE is that it is the main risk factor for the development of esophageal adenocarcinoma, whose incidence is currently growing faster than any other cancer in the Western world. The aim of this review was to compare the common treatment modalities of BE, with the focus on proton pump inhibitors and operative fundoplication. We performed a literature search on medical and surgical treatment of BE to determine eligible studies for this review. Studies on medical and surgical treatment of BE are discussed with regard to treatment effect on progression and regression of disease. Although there is some evidence for control of reflux with either medical or surgical therapy, there is no definitive evidence that either treatment modality decreases the risk of progression to dysplasia or cancer. Even though there is a trend toward antireflux surgery being superior, there are no definitive studies to prove this.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20698039      PMCID: PMC2921088          DOI: 10.3748/wjg.v16.i30.3773

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  42 in total

Review 1.  Clinical practice. Barrett's Esophagus.

Authors:  Stuart Jon Spechler
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

Review 2.  Management of nondysplastic Barrett's esophagus: where are we now?

Authors:  Prateek Sharma; Gary W Falk; Richard Sampliner; Stuart Jon Spechler; Kenneth Wang
Journal:  Am J Gastroenterol       Date:  2009-04       Impact factor: 10.864

Review 3.  Clinical practice. Barrett's esophagus.

Authors:  Prateek Sharma
Journal:  N Engl J Med       Date:  2009-12-24       Impact factor: 91.245

4.  Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus.

Authors:  Dang M Nguyen; Peter Richardson; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2010-02-23       Impact factor: 22.682

5.  Long-term outcome of antireflux surgery in patients with Barrett's esophagus.

Authors:  W L Hofstetter; J H Peters; T R DeMeester; J A Hagen; S R DeMeester; P F Crookes; P Tsai; F Banki; C G Bremner
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

Review 6.  Barrett's esophagus.

Authors:  Gary W Falk
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

7.  Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort.

Authors:  Piers A Gatenby; James R Ramus; Christine P Caygill; Marc C Winslet; Anthony Watson
Journal:  Eur J Cancer Prev       Date:  2009-09       Impact factor: 2.497

8.  Late results of the surgical treatment of 125 patients with short-segment Barrett esophagus.

Authors:  Attila Csendes; Italo Braghetto; Patricio Burdiles; Gladys Smok; Ana Henríquez; Ana Maria Burgos
Journal:  Arch Surg       Date:  2009-10

Review 9.  Barrett's esophagus: diagnostic challenges and recent developments.

Authors:  Dipen M Maru
Journal:  Ann Diagn Pathol       Date:  2009-04-01       Impact factor: 2.090

10.  Medication usage and the risk of neoplasia in patients with Barrett's esophagus.

Authors:  Dang M Nguyen; Hashem B El-Serag; Louise Henderson; Daniel Stein; Achyut Bhattacharyya; Richard E Sampliner
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-10       Impact factor: 11.382

View more
  5 in total

1.  Anti-reflux surgery does not remove cancer risk in Barrett's esophagus.

Authors:  Clive J Kelty; Gregory L Falk
Journal:  Surg Endosc       Date:  2011-12       Impact factor: 4.584

Review 2.  Diagnosis and management of Barrett's esophagus.

Authors:  Eric M Nelsen; Robert H Hawes; Prasad G Iyer
Journal:  Surg Clin North Am       Date:  2012-08-20       Impact factor: 2.741

3.  Gastroesophageal reflux disease: From heartburn to cancer.

Authors:  Marco G Patti; Irving Waxman
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

4.  The impact of laparoscopic anti-reflux surgery in patients with Barrett's esophagus.

Authors:  Ellen Morrow; Daniel Bushyhead; Eelco Wassenaar; Marcelo Hinojosa; Maximiliano Loviscek; Carlos Pellegrini; Brant Oelschlager
Journal:  Surg Endosc       Date:  2014-06-17       Impact factor: 4.584

Review 5.  Precision prevention of oesophageal adenocarcinoma.

Authors:  Thomas L Vaughan; Rebecca C Fitzgerald
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-02-10       Impact factor: 46.802

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.